Status:
COMPLETED
Prognostic Value of Plasma Lactate Levels Among Patients With Acute Pulmonary Embolism
Lead Sponsor:
Azienda Ospedaliero-Universitaria Careggi
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Brief Summary
To prospectively investigate the association between plasma lactate concentration and short-term adverse outcomes in patients with acute PE.
Detailed Description
Pulmonary embolism (PE) represents 0.4% of hospitalizations and is the third leading cause of death due to cardiovascular disease (1). In contrast to stroke and acute coronary syndromes, its mortality...
Eligibility Criteria
Inclusion
- Symptomatic objective pulmonary embolism
Exclusion
- life expectancies of less than 3 months
- first symptoms 15 day or more before inclusion.
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2014
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT01908231
Start Date
December 1 2012
End Date
February 1 2014
Last Update
February 19 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliero Universitaria Careggi, Emergency Department
Florence, Italy, 50134
2
Presidio Ospedaliero Livorno
Livorno, Italy
3
Azienda ospedaliera universitaria San Giovanni Battista (Molinette)
Torino, Italy
4
Respiratory Department and Medicine Department, Ramón y Cajal Hospital and Alcalá de Henares University
Madrid, Spain